Sadrettin Pence

Sadrettin Pence

Auto-generated profile, based on publicly available information

Sadrettin Pence

Istanbul University, Aziz Sancar Institute of Experimental Medicine (ASDETAE) , Department of Molecular Medicine , Istanbul , Turkey

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 November 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
FAFatemeh Azhari
Fatemeh Azhari
SPSadrettin Pence
Sadrettin Pence
MHMohammad Kazem Hosseini
Mohammad Kazem Hosseini
BBBurcin Karamustafaoglu Balci
Burcin Karamustafaoglu Balci
NCNazife Cevik
Nazife Cevik
TGTuba Gunel
Tuba Gunel
It has been identified that endometrium specific microRNAs have different expression levels in endometrial tissues and maternal serum during endometrial cycle. The aim of this study was to analyze ...

30 April 2021 in TURKISH JOURNAL OF MEDICAL SCIENCES
Verified
Journal Article
Open access
BYBurhanettin Yalçınkaya
Burhanettin Yalçınkaya
ETEsra Guzel Tanoglu
Esra Guzel Tanoglu
DTDidem Taşteki̇n
Didem Taşteki̇n
SPSadrettin Pençe
Sadrettin Pençe
Hepatocellular carcinoma (HCC) is one of the most aggressive cancer. MicroRNAs (miRNAs), are small noncoding regulatory RNAs, that function post-transcriptionally. MiRNA deregulation was observed in the development and progression of HCC. In this study we aimed to investigate the expression levels of four miRNA (mir-33a, mir-203b, mir361-3p and mir-424) in HCC patients in comparison to healthy individuals. Venous blood samples were collected from both HCC patients and healthy individuals. In order to determine relative expression levels of mir-33a, mir-203b, mir361-3p and hsa-mir-424 in HCC patients using probe-based Quantitative Real Time PCR (qRT-PCR) is performed. The cycle threshold (Ct) results were analyzed according to the 2???Ct method and statistical analyses was performed by IBM SPSS Statistics for Windows, version 15. qRT-PCR analysis revealed that the expression level of mir-33a (fold change: 7.3 and p<0,001), mir-203b (fold change: 4.6 and p<0,001), mir361-3p (fold change: 5.1 and p<0,001) were down regulated compared to healthy individuals and mir-424 did not show any significant change between the HCC patients and controls. Our results indicated that mir-33a, mir-203b and mir-361-3p, may significantly contribute to tumor pathogenesis in HCC and would have potential to be used as a non-invasive biomarker for cancer therapy.

1 January 2022 in Northern Clinics of Istanbul
Verified
Journal Article
Open access
SPSadrettin Pence
Sadrettin Pence
BPBurcu Caykara Peran
Burcu Caykara Peran
HPHalime Hanım PENÇE
Halime Hanım PENÇE
STSaban Tekin
Saban Tekin
BCBirsen Cevher-Keskin
Birsen Cevher-Keskin
OOOzturk Ozturk
Ozturk Ozturk
OBJECTIVE: Coronavirus disease 2019 (COVID-19), leading to mild infection (MI), acute respiratory distress syndrome or death in different persons. Although the basis of these variabilities has not been fully elucidated, some possible findings have been encountered. In the present study, we aimed to reveal genes with different expression profiles by next-generation sequencing of RNA isolated from blood taken from infected patients to reveal molecular causes of different response. METHODS: Two healthy, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-negative control individuals (NCI), two SARS-CoV-2-positive patients who have MI, and two patients who have critical infection (CI) were included in the study. Total RNA was extracted from blood samples and sequenced. Raw RNA-Seq data were analyzed on Galaxy platform for the identification of differentially expressed genes and their pathway involvements. RESULTS: We found that 199 and 521 genes were downregulated in whole blood of COVID-19-positive CI patients compared to NCI and MI patients, respectively. We identified 21 gene ontology pathways commonly downregulated in CI patients compared to both NCI and MI, mostly associated with innate and adaptive immune responses. Three hundred and fifty-four and 600 genes were found to be upregulated compared to NCI and MI, respectively. Upregulated six pathways included genes that function in inflammatory response and inflammatory cytokine release. CONCLUSION: The transcriptional profile of CI patients deviates more significantly from that of MI in terms of the number of differentially expressed genes, implying that genotypic differences may account for the severity of SARS-CoV-2 infection and inflammatory responses through differential regulation of gene expression. Therefore, further studies that involve whole genome analysis coupled with differential expression analysis are required in order to determine the dynamics of genotype - gene expression profile associations.

29 September 2021 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HGHilal Eren Gozel
Hilal Eren Gozel
KKKıvanç Kök
Kıvanç Kök
FOFatma Ozlen
Fatma Ozlen
CICihan Isler
Cihan Isler
SPSadrettin Pence
Sadrettin Pence
Cerebral cavernous malformation (CCM) is a vascular lesion of the central nervous system that may lead to distinct symptoms among patients including cerebral hemorrhages, epileptic seizures, focal neurologic deficits, and/or headaches. Disease-related mutations were identified previously in one of the three CCM genes: CCM1, CCM2, and CCM3. However, the rate of these mutations in sporadic cases is relatively low, and new studies report that mutations in CCM genes may not be sufficient to initiate the lesions. Despite the growing body of research on CCM, the underlying molecular mechanism has remained largely elusive. In order to provide a novel insight considering the specific manifested symptoms, CCM patients were classified into two groups (as Epilepsy and Hemorrhage). Since the studied patients experience various symptoms, we hypothesized that the underlying cause for the disease may also differ between those groups. To this end, the respective transcriptomes were compared to the transcriptomes of the control brain tissues and among each other. This resulted into the identification of the differentially expressed coding genes and the delineation of the corresponding differential expression profile for each comparison. Notably, some of those differentially expressed genes were previously implicated in epilepsy, cell structure formation, and cell metabolism. However, no CCM1-3 gene deregulation was detected. Interestingly, we observed that when compared to the normal controls, the expression of some identified genes was only significantly altered either in Epilepsy (EGLN1, ELAVL4, and NFE2l2) or Hemorrhage (USP22, EYA1, SIX1, OAS3, SRMS) groups. To the best of our knowledge, this is the first such effort focusing on CCM patients with epileptic and hemorrhagic symptoms with the purpose of uncovering the potential CCM-related genes. It is also the first report that presents a gene expression dataset on Turkish CCM patients. The results suggest that the new candidate genes should be explored to further elucidate the CCM pathology. Overall, this work constitutes a step towards the identification of novel potential genetic targets for the development of possible future therapies.

4 December 2021 in Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology
Verified
Journal Article
Open access
BPBurcu Caykara Peran
Burcu Caykara Peran
BTBengü Tokat
Bengü Tokat
ECEnder Coşkunpınar
Ender Coşkunpınar
OKOzlem Kucukhuseyin
Ozlem Kucukhuseyin
DDDeniz Kanca Demirci
Deniz Kanca Demirci
HAHülya Yılmaz Aydoğan
Hülya Yılmaz Aydoğan
The scavenger receptor class B type 1 (SR-BI, SCARB1), which is a high-density lipoprotein (HDL) receptor that mediates selective cholesteryl ester uptake, plays an important role in reverse cholesterol transport. This study investigated the distribution of polymorphic variants of the SR-BI gene in patients with coronary heart disease (CHD) with a history of early myocardial infarction (MI) at an early age and their effects on their serum lipid levels. SR-BI rs5888(T>C), rs4238001(C>T), and rs10846744(G>C) were analyzed in 100 male patients with CHD with a history of MI (MI+) who were younger than 50 years and 89 male control subjects without MI history (MI-) using real-time polymerase chain reaction (PCR) and mutant-allele-specific PCR techniques. SR-BI rs4238001 common-CC genotype was found to be more frequent in patients with MI+ than in control subjects (MI-; odds ratio 4.046, p<0.001). The rs10846744 rare-C allele showed a significant association with increased total cholesterol (p=0.014) and triglyceride (p=0.009) levels in the MI+ CHD group. Logistic regression analysis confirmed that there may be an association between the rs4238001-CC genotype (p=0.002), smoking (p=0.026), and MI+ CHD in the presence of other risk factors associated with CHD, whereas haplotype analysis confirmed that patients with MI+ CHD (rs5888-C, rs10846744-G, and rs4238001-C alleles) and CCC (rs5888-C, rs10846744-C, and rs4238001-C alleles) haplotypes were highly frequent (p<0.01 and p=0.027, respectively). These results indicated that SR-BI gene variants show different distribution in patients with MI+ CHD compared with that in MI- control subjects, and these variants may have effects in favor of dyslipidemia.

4 July 2022 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
EAEfruz Pirdogan Aydin
Efruz Pirdogan Aydin
HAHani Alsaadoni
Hani Alsaadoni
ABAzra Gokovali Begenen
Azra Gokovali Begenen
OOOmer Akil Ozer
Omer Akil Ozer
KKKayihan Oguz Karamustafalioglu
Kayihan Oguz Karamustafalioglu
SPSadrettin Pence
Sadrettin Pence
Epigenetics,miRNA,obsessive-compulsive disorder,severity,treatment resistance